cipars picra - Antibiotic Awareness

More documents

Recommendations

Info

18 Antimicrobial consumption (DDDs/1,000 inhabitant-days) in 30 European countries and Canada: European Surveillance of Antimicrobial Consumption and CIPARS 2008. 50.00 45.00 40.00 35.00 30.00 25.00 20.00 DDD/1000 inhabitants 15.00 10.00 5.00 0.00 Greece Cyprus Italy France Belgium Luxembourg Lithuania Slovakia Croatia Portugal Ireland Israel Poland Iceland Bulgaria Spain Finland Canada Czech_Republic United_Kingdom Denmark Norway Hungary Austria Slovenia Sweden Germany Estonia Netherlands Latvia Russian_Federation Penicillins (J01C) Tetracyclines (J01A) Quinolones (J01M) Cephalosporins and other b-lactams (J01D) Macrolides, lincosamides, Country and steptogramins (J01F) Sulphonamides and trimethoprim (J01E) Others (J01B+J01G+J01X+J01DF+J01DH)
Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006) 19 Macrolide DDDs per capita 0.28 0.24 0.20 0.16 0.12 (a) 240 260 280 300 320 340 360 380 Health workers per 10 000 individuals Erythromycin DDDs per capita 0.016 0.012 0.008 0.004 0.000 (b) 6 8 10 12 14 16 18 Percent education Azithromycin DDDs per capita 0.04 0.03 0.02 0.01 (a) 6 8 10 12 14 16 18 Percent education Clarithromycin DDDs per capita 0.16 0.14 0.12 0.10 0.08 0.06 (c) 50 55 60 65 70 75 80 Median family income (1000's) Macrolide DDDs per capita 0.32 0.28 0.24 0.20 0.16 0.12 (d) 10 12 14 16 18 20 22 Percent low income Azithromycin DDDs per capita 0.05 0.04 0.03 0.02 0.01 (b) 50 55 60 65 70 75 80 Median family income (1000's) Macrolide DDDs per capita 0.28 0.24 0.20 0.16 0.12 (e) 2 4 6 8 10 12 14 16 18 20 Percent unemployment Macrolide DDDs per capita 0.24 0.22 0.20 0.18 0.16 0.14 0.12 0.10 (f) 0.0 0.5 1.0 1.5 2.0 Reported influenza cases per 10 000 Azithromycin DDDs per capita 0.05 0.04 0.03 0.02 0.01 (c) 10 12 14 16 18 20 Percent low income Glass SK, Pearl DL, McEwen SA, Finley R. 2010. A Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006). Journal of Antimicrobial Chemotherapy. 65: 148-155
Page 2 and 3: Canadian Integrated Program for Ant
Page 4 and 5: Canadian Integrated Program for Ant
Page 6 and 7: 6 Canadian Integrated Program for A
Page 8 and 9: Retail Meat Surveillance Random cen
Page 10 and 11: Human Surveillance • Full data co
Page 12 and 13: 12 ANTIMICROBIAL CLASSIFICATION SYS
Page 14 and 15: Surveillance and Research Findings
Page 16 and 17: Human Systemic Anti-bacterials Disp
Page 20 and 21: 20 A province-level risk factor ana
Page 22 and 23: 22 Antimicrobial use in laboratory
Page 24 and 25: Antimicrobial use by importance to
Page 26 and 27: Resistance to antimicrobials in Esc
Page 28 and 29: 28 Ceftiofur resistance in chicken

cipars picra - Antibiotic Awareness

Create successful ePaper yourself

Delete template?

Save as template?